共 454 条
[51]
Gent M(1996)Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases J Clin Oncol 14 1943-81
[52]
Pincus T(1995)Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study Am J Med 99 276-56
[53]
Marcum SB(1995)Sulfasalazine: a review of its pharmacological properties and therapeutic efficacy in treatment of rheumatoid arthritis Drugs 50 137-51
[54]
Callahan LF(1972)Absorption, metabolism and excretion of salicylazo-sulfapyridine in man Clin Pharmacol Ther 13 539-8
[55]
Boers M(1985)Which component of sulphasalazine is active in rheumatoid arthritis BMJ 290 1535-51
[56]
Verhoeven AC(1990)The use of sulfasalzine as a disease modifyinig antirheumatic drug Baillieres Clin Rheumatol 4 535-9
[57]
Markusse HM(1995)Sulphasalzine, sulfapyridine or 5-aminosalicylic acid-which is the active moiety in rheumatoid arthitis Br J Rheumatol 35 16-402
[58]
O’Dell JR(1987)Effect of sulphasalazine on the radiological progression of rheumatoid arthritis Ann Rheum Dis 46 398-8
[59]
Haire CE(1989)Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis Lancet I 1036-8
[60]
Erikson N(2000)Alternative methods for analysis of radiographic damage in a randomized, double-blind, parallel group clinical trial comparing hydroxychloroquine and sulfasalazine J Rheumatol 27 535-30